Alnylam Pharmaceuticals Inc (ALNY) — Free Cash Flow Generation Index
Alnylam Pharmaceuticals Inc (ALNY) has a Free Cash Flow Generation Index of 0.86x as of December 2025. Free cash flow of $140.26 Million represents 1% of operating cash flow ($163.56 Million). Explore ALNY capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Alnylam Pharmaceuticals Inc Free Cash Flow Generation Index (2007–2025)
Historical FCF Generation Index trend for Alnylam Pharmaceuticals Inc across 4 annual periods. For the full cash flow conversion analysis, see Alnylam Pharmaceuticals Inc cash conversion from operations.
Annual Free Cash Flow Generation for Alnylam Pharmaceuticals Inc (2007–2025)
Year-by-year Free Cash Flow Generation Index for Alnylam Pharmaceuticals Inc. Check how aggressively does Alnylam Pharmaceuticals Inc reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.89x | $465.38 Million | $524.08 Million | $58.70 Million | ▲ +120.5% |
| 2023 | 0.40x | $41.95 Million | $104.16 Million | $62.21 Million | ▼ -51.8% |
| 2008 | 0.84x | $54.73 Million | $65.49 Million | $10.76 Million | ▼ -13.0% |
| 2007 | 0.96x | $188.73 Million | $196.52 Million | $7.79 Million | — |